Study ID: 110635 Clinical Study ID: 110635 Study Title: A double-blind, randomized, placebo controlled, parallel group, multi-center, phase III trial of ofatumumab investigating clinical efficacy in adult patients with active rheumatoid arthritis who had an inadequate response to methotrexate therapy (FINAL ANALYSIS: follow-up period and cumulative safety data across the whole study) Patient Level Data: Study Listed on Identifier: NCT00611455 Sponsor: GlaxoSmithKline Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ofatumumab, Placebo Study Indication: Arthritis, Rheumatoid

Versions (1) ▾
  1. 3/25/20
Copyright Holder:
Uploaded on:

March 25, 2020

No DOI assigned. To request one please log in.
Creative Commons BY-NC 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Efficacy of ofatumumab in adult patients with active rheumatoid arthritis with inadequate response to methotrexate NCT00611455

Early Withdrawal - ESR; PK Blood Sample; Biomarker Samples; Transcriptomic Research Sample Collection; Liver Events; Investigational Product Discontinuation

PK Blood Sample - Point in Time Collection
Sample taken?
Biomarker Samples
Has sample been collected?
If sample has not been collected, provide reason
Transcriptomic Research Sample Collection Details
Has a blood sample been collected for transcriptomic research?
Liver Event Assessment
Have liver chemistry results reached or exceeded protocol-defined investigational product stopping criteria?
Investigational Product Discontinuation
Was the subject withdrawn from future infusions of investigational product?
Select primary reason the investigational product was stopped